Last: | $3.35 |
---|---|
Change Percent: | 2.13% |
Open: | $3.27 |
Close: | $3.28 |
High: | $3.45 |
Low: | $3.27 |
Volume: | 12,047 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.35 | $3.27 | $3.28 | $3.45 | $3.27 | 12,047 | 04-26-2024 |
$3.28 | $3.33 | $3.28 | $3.4045 | $3.2 | 6,352 | 04-25-2024 |
$3.4 | $3.35 | $3.4 | $3.4 | $3.35 | 4,487 | 04-24-2024 |
$3.39 | $3.51 | $3.39 | $3.52 | $3.39 | 7,829 | 04-23-2024 |
$3.5 | $3.55 | $3.5 | $3.565 | $3.45 | 5,397 | 04-22-2024 |
$3.49 | $3.56 | $3.49 | $3.56 | $3.42 | 6,952 | 04-19-2024 |
$3.53 | $3.56 | $3.53 | $3.57 | $3.4 | 7,831 | 04-18-2024 |
$3.49 | $3.3 | $3.49 | $3.49 | $3.2501 | 13,727 | 04-17-2024 |
$3.45 | $3.28 | $3.45 | $3.6299 | $3.28 | 10,371 | 04-16-2024 |
$3.39 | $3.49 | $3.39 | $3.49 | $3.26 | 10,068 | 04-15-2024 |
$3.45 | $3.18 | $3.45 | $3.45 | $3.17 | 24,393 | 04-12-2024 |
$3.22 | $3.21 | $3.22 | $3.49 | $3.1 | 28,653 | 04-11-2024 |
$3.22 | $3.11 | $3.22 | $3.4353 | $3.1 | 23,852 | 04-10-2024 |
$3.1 | $2.81 | $3.1 | $3.2 | $2.51 | 77,767 | 04-09-2024 |
$2.82 | $2.66 | $2.82 | $3.1 | $2.6 | 77,392 | 04-08-2024 |
$2.64 | $2.77 | $2.64 | $2.77 | $2.55 | 37,489 | 04-05-2024 |
$2.7 | $2.9 | $2.7 | $2.9 | $2.6966 | 28,127 | 04-04-2024 |
$2.8 | $2.87 | $2.8 | $2.9778 | $2.75 | 30,443 | 04-03-2024 |
$2.735 | $3.04 | $2.735 | $3.04 | $2.71 | 22,229 | 04-02-2024 |
$2.99 | $3.1 | $2.99 | $3.1 | $2.95 | 19,563 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aspira Women's Health Inc. Company Name:
AWH Stock Symbol:
NASDAQ Market:
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced a new...
2024-04-01 09:15:06 ET Cantor Fitzgerald analyst issues NEUTRAL recommendation for AWH on April 1, 2024 07:36AM ET. The previous analyst recommendation was Neutral. AWH was trading at $3.1 at issue of the analyst recommendation. Historical Analyst Recommendations L...
2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth quarter and full-year 2023 to $3.5 million and $15.9 million, respectively Confer...